Described is a process for making a dry and stable hemostatic composition, said process comprisinga) providing a dry granular preparation of a biocompatible polymer suitable for use in hemostasis,b) coating the granules in said dry granular preparation with a preparation of a coagulation inducing agent, thereby obtaining coagulation inducing agent coated polymer granules,c) filling said coagulation inducing agent coated polymer granules into a final container,d) finishing the final container to a storable pharmaceutical device containing said coagulation inducing agent coated polymer granules as a dry and stable hemostatic composition.
